- Home
- AAT vs SLNO Comparison
AAT vs SLNO Comparison
Compare AAT & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAT | SLNO |
|---|---|---|
| Founded | 1967 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 2.5B |
| IPO Year | 2011 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AAT | SLNO |
|---|---|---|
| Price | $18.90 | $47.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $20.50 | ★ $110.90 |
| AVG Volume (30 Days) | 431.2K | ★ 1.3M |
| Earning Date | 02-03-2026 | 11-04-2025 |
| Dividend Yield | ★ 7.20% | N/A |
| EPS Growth | ★ 5.06 | N/A |
| EPS | ★ 1.02 | N/A |
| Revenue | ★ $435,170,000.00 | $98,675,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.09 | $155.86 |
| P/E Ratio | $18.60 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.69 | $41.50 |
| 52 Week High | $26.66 | $90.32 |
Technical Indicators
Market Signals| Indicator | AAT | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 44.61 | 42.01 |
| Support Level | $18.57 | $47.01 |
| Resistance Level | $19.46 | $49.75 |
| Average True Range (ATR) | 0.32 | 2.37 |
| MACD | -0.02 | 0.12 |
| Stochastic Oscillator | 33.68 | 8.91 |
Price Performance
Historical ComparisonAbout AAT American Assets Trust Inc.
American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.